Natural history of covert hepatic encephalopathy: An observational study of 366 cirrhotic patients

World J Gastroenterol. 2017 Sep 14;23(34):6321-6329. doi: 10.3748/wjg.v23.i34.6321.

Abstract

Aim: To explore the natural history of covert hepatic encephalopathy (CHE) in absence of medication intervention.

Methods: Consecutive outpatient cirrhotic patients in a Chinese tertiary care hospital were enrolled and evaluated for CHE diagnosis. They were followed up for a mean of 11.2 ± 1.3 mo. Time to the first cirrhosis-related complications requiring hospitalization, including overt HE (OHE), resolution of CHE and death/transplantation, were compared between CHE and no-CHE patients. Predictors for complication(s) and death/transplantation were also analyzed.

Results: A total of 366 patients (age: 47.2 ± 8.6 years, male: 73.0%) were enrolled. CHE was identified in 131 patients (35.8%). CHE patients had higher rates of death and incidence of complications requiring hospitalization, including OHE, compared to unimpaired patients. Moreover, 17.6% of CHE patients developed OHE, 42.0% suffered persistent CHE, and 19.8% of CHE spontaneously resolved. In CHE patients, serum albumin < 30 g/L (HR = 5.22, P = 0.03) was the sole predictor for developing OHE, and blood creatinine > 133 μmol/L (HR = 4.75, P = 0.036) predicted mortality. Child-Pugh B/C (HR = 0.084, P < 0.001) and OHE history (HR = 0.15, P = 0.014) were predictors of spontaneous resolution of CHE.

Conclusion: CHE exacerbates, persists or resolves without medication intervention in clinically stable cirrhosis. Triage of patients based on these predictors will allow for more cost-effect management of CHE.

Keywords: Covert hepatic encephalopathy; Liver cirrhosis; Natural history; Overt hepatic encephalopathy.

Publication types

  • Comparative Study
  • Observational Study

MeSH terms

  • Adult
  • Cost-Benefit Analysis
  • Female
  • Follow-Up Studies
  • Hepatic Encephalopathy / diagnosis*
  • Hepatic Encephalopathy / economics
  • Hepatic Encephalopathy / mortality
  • Hepatic Encephalopathy / therapy
  • Hospitalization / statistics & numerical data*
  • Humans
  • Incidence
  • Liver Cirrhosis / complications*
  • Liver Cirrhosis / economics
  • Liver Cirrhosis / mortality
  • Liver Cirrhosis / therapy
  • Liver Transplantation / statistics & numerical data*
  • Male
  • Middle Aged
  • Quality of Life
  • Remission, Spontaneous
  • Triage